Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EWING 2008 International
DRKS00003588Phase 3Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Mar 2012
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 13
01
Overview
Phase 3, randomised trial of zoledronic acid, busulfan, melphalan and treosulfan in Ewing sarcoma, neuroectodermal tumor, Ewing sarcoma of the chest wall and 1 more (8 arms), sponsored by Universitätsklinikum Münster. Started Mar 2012; status: completed.
02
Drugs
zoledronic acidbusulfanmelphalantreosulfan
03
Conditions
Ewing sarcomaneuroectodermal tumorEwing sarcoma of the chest wallbone cancer
Beyond the preview
Go deeper on DRKS00003588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003588.